Market cap
$2.542 B
$11.65 -6.54%
Close of 6 Nov 2026
As of 6 Nov 2026, Neogen (NEOG) has a market capitalization of $2.54B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
$870.4M
#1590 by revenue
Earnings
-$7.90M
Loss-making
Shares outstanding
218,306,034
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Biotechnology: In Vitro & In Vivo Diagnostic Substances, ranked by market cap
All 19 →- #2LantheusLNTH$6.58B
- #3Oruka TherapeuticsORKA$6.36B
- #4NeogenNEOG$2.54B
- #5Celldex TherapeuticsCLDX$2.22B
- #6Intellia TherapeuticsNTLA$1.56B
What if Neogen were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Neogen are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.